Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Lack of clinical trial data may hinder treatment decision-making in older women
December 29th, 2005
The lack of clinical trial data may hinder treatment decision-making in older women. According to investigators in the United States "Node (+) breast cancer represents over 40% of cases in older women and currently there is a debate whether adjuvant therapy for all older women is cost-effective. [The purpose of our study was] to evaluate if adjuvant treatment for early-stage (Stage I-IIIa) node (+) breast cancer with hormone therapy, chemotherapy, or combination therapy is cost-effective in older patients." "[The study design was] a decision-analysis model for 65, 75, and 85 year-old female breast cancer patients using life tables integrated the cost...
Source: Women's Health Weekly (2005-12-29)
|
